An open-ended equity scheme following Multi-national Companies (MNC) theme
An open-ended equity scheme following Multi-national Companies (MNC) theme
 |
 |
 
|
|
|
|
The investment objective of the scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC). However, there is no assurance that the objective of the scheme will be achieved.
The investment objective of the scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC). However, there is no assurance that the objective of the scheme will be achieved.
| Issuer/Instrument | |
% to Net Assets |
|---|---|---|
| Equity & Equity related |
||
| Pharmaceuticals and Biotechnology | 12.18 | |
| Sun Pharmaceuticals Industries Ltd. | 2.35 | |
| Glenmark Pharmaceuticals Ltd | 1.94 | |
| Marksans Pharma Ltd | 1.93 | |
| JB CHEMICALS & PHARMACEUTICALS LTD. | 1.84 | |
| JUBILANT PHARMOVA LIMITED | 1.68 | |
| ORCHID PHARMA LTD. | 1.01 | |
| AMI ORGANICS LTD | 0.90 | |
| SAI LIFE SCIENCES LIMITED | 0.53 | |
| IT - Software | 10.88 | |
| Oracle Financial Services Software Ltd | 3.84 | |
| Infosys Ltd. | 2.68 | |
| Tech Mahindra Ltd. | 2.65 | |
| Mphasis Ltd | 1.71 | |
| Electrical Equipment | 8.70 | |
| Siemens Ltd. | 3.39 | |
| ABB India Ltd | 2.14 | |
| GE VERNOVA T&D INDIA LIMITED | 1.85 | |
| AZAD ENGINEERING LTD | 1.32 | |
| Food Products | 8.28 | |
| Britannia Industries Ltd. | 5.16 | |
| NESTLE INDIA LTD. | 3.12 | |
| Diversified FMCG | 7.21 | |
| Hindustan Unilever Ltd. | 7.21 | |
| Automobiles | 7.07 | |
| Maruti Suzuki India Limited | 7.07 | |
| Auto Components | 4.63 | |
| Schaeffler India Ltd | 1.69 | |
| Bosch Ltd. | 1.33 | |
| SAMVARDHANA MOTHERSON INTERNATIONAL LIMITED | 0.85 | |
| SONA BLW PRECISION FORGINGS LTD | 0.76 | |
| Industrial Products | 3.95 | |
| Timken India Ltd. | 1.63 | |
| Cummins India Ltd. | 1.54 | |
| KSB LTD | 0.78 | |
| Beverages | 3.78 | |
| UNITED SPIRITS LTD. | 3.78 | |
| Healthcare Services | 3.19 | |
| ASTER DM HEALTHCARE LTD | 1.66 | |
| Fortis Healthcare India Ltd | 1.53 | |
| Retailing | 3.05 | |
| SWIGGY LTD | 3.05 | |
| Chemicals and Petrochemicals | 2.40 | |
| Tata Chemicals Ltd | 2.40 | |
| Telecom - Services | 2.26 | |
| Bharti Airtel Ltd | 2.26 | |
| Capital Markets | 1.88 | |
| Nippon Life India Asset Management Ltd. | 1.88 | |
| Finance | 1.70 | |
| CRISIL Ltd. | 1.70 | |
| Personal Products | 1.70 | |
| Colgate Palmolive (India ) Ltd. | 1.70 | |
| Agricultural, Commercial and Constr | 1.68 | |
| Ashok Leyland Ltd. | 1.68 | |
| Industrial Manufacturing | 1.23 | |
| Tega Industries Ltd. | 1.23 | |
| Aerospace and Defense | 1.22 | |
| MTAR Technologies Ltd. | 1.22 | |
| Equity & Equity related - Total | 86.99 | |
| Triparty Repo | 13.20 | |
| Net Current Assets/(Liabilities) | -0.19 | |
| Grand Total | 100.00 | |
| | ||
| Regular | Direct | |
| Growth | Rs10.0980 | Rs10.1240 |
| IDCW | Rs10.0980 | Rs10.1240 |
A) Regular Plan B) Direct Plan
Options: Growth and Income Distribution
cum capital withdrawal (IDCW) (Payout and
Reinvestment)
| Fund Manager* |
Mr. Harsha Upadhyaya, Mr. Dhananjay Tikariha & Mr. Abhishek Bisen |
| Benchmark | Nifty MNC Index TRI |
| Allotment date | October 28, 2024 |
| AAUM | Rs2,408.69 crs |
| AUM | Rs2,381.91 crs |
| Folio count | 1,19,172 |
Trustee's Discretion
| ^^(P/E) | 56.89 |
| ^^P/BV | 7.60 |
Initial & Additional Investment
• Rs100 and any amount thereafter
Systematic Investment Plan (SIP)
• Rs 100 and any amount thereafter
• 5 years & above
Entry Load: Nil. (applicable for all plans)
Exit Load:
• For redemption / switch out within 90
days from the date of allotment: 0.5%
• If units are redeemed or switched out on
or after 90 days from the date of allotment -
Nil
| Regular Plan: | 1.96% |
| Direct Plan: | 0.46% |
Folio Count data as on 30th November 2024.
Benchmark : Nifty MNC Index TRI
This product is suitable for investors who are seeking*:
- Long-term capital growth
- Investment in portfolio of predominantly in equity and equity related securities of multi-national companies (MNC).
* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.
The above risk-o—meter is based on the scheme portfolio as on 30th November, 2024. An addendum may be issued or updated on the website for new riskometer.
Scheme has not completed 6 months since inception
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'